In contrast, CML cell lines K-562 and TK-6 are BCR::ABL1-positive and, thus, bear 22q11.23 alterations, which are cytogenetically indistinguishable from potential TBX1 rearrangements. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.